Rethinking CLDN18.2 expression in gastric cancer therapy – Authors' reply

The Lancet 2026

View at publisher

Authors: Chang Liu, Z. Peng, Changsong Qi, Lin Shen

DOI: 10.1016/s0140-6736(25)02356-6

Cited by: 0

References: 4

Fields of Study & Subjects

Barrier Structure and Function Studies Caveolin-1 and cellular processes HER2/EGFR in Cancer Research

References 4